Article Per Year (5 Year)
p-Index From 2021 - 2026
0
P-Index
This Author published in this journals
All Journal Cermin Dunia Kedokteran
Haurissa, Andreas Erick
Unknown Affiliation
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Gamma-Glutamyltransferase Sebagai Biomarker Risiko Penyakit Kardiovaskuler Haurissa, Andreas Erick
Cermin Dunia Kedokteran Vol 41, No 11 (2014): Infeksi
Publisher : PT. Kalbe Farma Tbk.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (263.513 KB) | DOI: 10.55175/cdk.v41i11.1069

Abstract

Peningkatan kadar gamma-glutamyltransferase (GGT) telah banyak dimanfaatkan dalam praktik klinis terutama pada penyakit hepatobiliaris. Di samping itu, GGT diketahui berperan dalam degradasi gluthatione (GSH) sehingga memicu stres oksidatif, aterogenesis, rupturnya plak ateroma, dan gagal jantung Karena karakteristiknya yang khusus, GGT kemudian diteliti dalam kaitannya dengan penyakit kardiovaskuler. Dari sebagian besar penelitian yang telah dilakukan, GGT tampaknya mampu menjadi biomarker penyakit kardiovaskuler yang menjanjikan, baik untuk hal terapeutik maupun prognostik.Increased gamma-glutamyltransferase (GGT) level has been widely used as marker in clinical practice, especially in hepatobiliary disease. GGT has also a role in the degradation of glutathione (GSH), which triggers the oxidative stress, atherogenesis, ateroma plaque rupture, and consequently, heart failure. Because of its special characteristics, the role of GGT is widely investigated in cardiovascular disease. Current studies indicated that GGT is a candidate to become a novel and promising biomarker for cardiovascular risk, therapy, and prognosis.
Co-Authors